Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
The RAS Revolution: A Deep Dive into Revolution Medicines’ Path to Dominance (2026 Report)
Via Finterra
Topics Economy Initial Public Offering Intellectual Property
Tickers ABBV AMGN BLK BMY LLY MRK
Exposures Intellectual Property Interest Rates Product Safety
News headline image
The New J&J: A 2026 Deep Dive into the Global Healthcare Titan
Via Finterra
Topics Artificial Intelligence Death Economy
Tickers BLK C JNJ KVUE MDT MS
Exposures Artificial Intelligence COVID-19 Death
News headline image
Travere Therapeutics Stock Skyrockets On FDA Approval ↗
Via Investor's Business Daily
Exposures Product Safety
News headline image
Why Is Plus Therapeutics Stock Gaining Friday? ↗
Via Benzinga
Exposures Product Safety
News headline image
Pureluxtech Expands FDA-Cleared Red Light Therapy Portfolio for Global Wellness Brands OEM/ODM Manufacturer
Via Get News
Exposures Product Safety
News headline image
Cora Health Expands Telehealth Access to GLP-1 Medications Across 44 States
Via AB Newswire
Exposures Product Safety
News headline image
$30 Billion Per Year US Heart Failure Market Presents Huge Opportunity for Promising Drugs Advancing with Positive Trial Results for Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)
Via Get News
Topics Intellectual Property
Tickers CRDL LLY TSX:CRDL
Exposures Intellectual Property Product Safety
News headline image
Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?
Via Barchart.com
Exposures Product Safety
Why FDA Warehouse Inspections Catch More Businesses Off Guard Than They Should
Via BusinesNews Wire
Exposures Product Safety
News headline image
FDA Rejection Sparks Questions On Replimune Drug Approval Path ↗
Via Benzinga
Exposures Product Safety
News headline image
Ocular's Axpaxli Cuts Risk Of Worsening In Late-Stage AMD Study ↗
Via Benzinga
Tickers AMD
Exposures Product Safety
News headline image
Diclosan: The Modern Standard for Safe & Effective Disinfection
Via AB Newswire
Exposures Product Safety
News headline image
Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens
Via MarketMinute
Tickers ANIK ORGO PCRX SYK ZBH
Exposures Product Safety
News headline image
Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity
Via MarketMinute
Topics Economy
Tickers ASND AZN BBIO BMRN
Exposures Interest Rates Product Safety
News headline image
Amgen’s Subcutaneous TEPEZZA Data Sets New Gold Standard for Thyroid Eye Disease Treatment
Via MarketMinute
Tickers AMGN IMVT VRDN
Exposures Product Safety
News headline image
Kaplan Fox Reminds ImmunityBio, Inc. (NASDAQ: IBRX) Investors of a Securities Class Action Deadline on May 26, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Reminds ImmunityBio, Inc. (NASDAQ: IBRX) Investors of a Securities Class Action Deadline on May 26, 2026
Via NewMediaWire
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
The Radiopharmaceutical Renaissance: A Deep Dive into Telix Pharmaceuticals (TLX)
Via Finterra
Topics Economy Initial Public Offering
Tickers ASX:TLX ASX:XJO FIS JPM LLY NVS
Exposures Product Safety Securities Market Supply Chain
News headline image
The Science of Scale: An In-Depth Look at Regeneron Pharmaceuticals (REGN) in 2026
Via Finterra
Topics Earnings Economy Intellectual Property
Tickers ABBV AMGN LLY MRK REGN RHHBY
Exposures Financial Intellectual Property Interest Rates
News headline image
CORT SHAREHOLDER ACTION ALERT: Kaplan Fox Alerts Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
CORT SHAREHOLDER ACTION ALERT: Kaplan Fox Alerts Investors of a Class Action Lawsuit Against Corcept Therapeutics, Inc. (NASDAQ: CORT) and Lead Plaintiff Deadline on April 21, 2026
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
Is This Dividend King With a 63-Year Dividend Streak A Buy Before April 14?
Via Barchart.com
Tickers JNJ
Exposures Product Safety
News headline image
Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
Via Newsfile
Tickers PHIO
Exposures Product Safety
News headline image
Q4 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks
Via StockStory
Topics Artificial Intelligence
Tickers DXCM
Exposures Artificial Intelligence Product Safety
News headline image
DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Deadline is April 21, 2026
Via TheNewswire.com
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Deadline is April 21, 2026
Via NewMediaWire
Topics Lawsuit
Tickers CORT
Exposures Financial Legal Product Safety
News headline image
IMMUNITYBIO Deadline to Lead in Securities Class Action Lawsuit is May 26, 2026 - Contact Kaplan Fox
Via TheNewswire.com
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
IMMUNITYBIO Deadline to Lead in Securities Class Action Lawsuit is May 26, 2026 - Contact Kaplan Fox
Via NewMediaWire
Topics Lawsuit
Tickers IBRX
Exposures Financial Legal Product Safety
News headline image
Striking Beauties Boxing & Fitness Launches Women-Only Franchise
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
News headline image
FDA Again Rejects Replimune Skin Cancer Therapy, Says Evidence Falls Short ↗
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.